G Rylance

2.3k total citations
54 papers, 1.6k citations indexed

About

G Rylance is a scholar working on Pediatrics, Perinatology and Child Health, Clinical Biochemistry and Psychiatry and Mental health. According to data from OpenAlex, G Rylance has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pediatrics, Perinatology and Child Health, 16 papers in Clinical Biochemistry and 10 papers in Psychiatry and Mental health. Recurrent topics in G Rylance's work include Metabolism and Genetic Disorders (16 papers), Pharmaceutical studies and practices (14 papers) and Pharmacological Effects and Toxicity Studies (9 papers). G Rylance is often cited by papers focused on Metabolism and Genetic Disorders (16 papers), Pharmaceutical studies and practices (14 papers) and Pharmacological Effects and Toxicity Studies (9 papers). G Rylance collaborates with scholars based in United Kingdom, United States and Australia. G Rylance's co-authors include Anita MacDonald, D. Asplin, I W Booth, T. A. Moreland, S. K. Hall, Alan J. Thompson, D. P. Brenton, Michael Schmidt, Andy Vail and F. White and has published in prestigious journals such as The Lancet, Archives of Disease in Childhood and British Journal of Clinical Pharmacology.

In The Last Decade

G Rylance

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Rylance United Kingdom	23	900	587	493	482	197	54	1.6k
Matti K. Salo Finland	27	322 0.4×	356 0.6×	419 0.8×	386 0.8×	107 0.5×	71	2.3k
Allen M. Glasgow United States	17	478 0.5×	172 0.3×	295 0.6×	314 0.7×	58 0.3×	39	1.1k
Scott C. Denne United States	27	244 0.3×	415 0.7×	692 1.4×	173 0.4×	99 0.5×	86	2.1k
F Sereni Italy	20	182 0.2×	156 0.3×	699 1.4×	528 1.1×	66 0.3×	75	1.8k
Thomas Pozefsky United States	19	272 0.3×	1.0k 1.8×	78 0.2×	269 0.6×	33 0.2×	27	2.1k
Shikha S. Sundaram United States	26	92 0.1×	437 0.7×	266 0.5×	236 0.5×	61 0.3×	72	2.9k
Richard A. Iles United Kingdom	11	134 0.1×	119 0.2×	222 0.5×	160 0.3×	52 0.3×	39	780
Erica M. Fallon United States	23	123 0.1×	303 0.5×	250 0.5×	159 0.3×	129 0.7×	47	1.7k
Frederick C. Whittier United States	20	269 0.3×	136 0.2×	108 0.2×	184 0.4×	38 0.2×	51	1.5k
Peter Stewart United Kingdom	23	82 0.1×	178 0.3×	229 0.5×	138 0.3×	52 0.3×	75	1.5k

Countries citing papers authored by G Rylance

Since Specialization

Citations

This map shows the geographic impact of G Rylance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Rylance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Rylance more than expected).

Fields of papers citing papers by G Rylance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Rylance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Rylance. The network helps show where G Rylance may publish in the future.

Co-authorship network of co-authors of G Rylance

This figure shows the co-authorship network connecting the top 25 collaborators of G Rylance. A scholar is included among the top collaborators of G Rylance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Rylance. G Rylance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rylance, G, et al.. (2009). QUESTION 1. Normal CSF: does it exclude meningitis?. Archives of Disease in Childhood. 94(12). 988–991. 7 indexed citations

Tse, Yincent & G Rylance. (2008). Emergency management of anaphylaxis in children and young people: new guidance from the Resuscitation Council (UK). Archives of Disease in Childhood Education & Practice. 94(4). 97–101. 14 indexed citations

Elias-Jones, A C & G Rylance. (2005). The launch of the British National Formulary for Children. Archives of Disease in Childhood. 90(10). 997–998. 4 indexed citations

Wassmer, Evangeline, Esha Gupta, G Rylance, et al.. (2001). General Paediatrics. Archives of Disease in Childhood. 84(90001). 35a–37.

Rylance, G. (1999). Privacy, dignity, and confidentiality: interview study with structured questionnaire. BMJ. 318(7179). 301–301. 22 indexed citations

Armstrong, David & G Rylance. (1999). Definitive diagnosis of nut allergy. Archives of Disease in Childhood. 80(2). 175–177. 13 indexed citations

MacDonald, Anita, G Rylance, D. Asplin, S. K. Hall, & I W Booth. (1998). Does a single plasma phenylalanine predict quality of control in phenylketonuria?. Archives of Disease in Childhood. 78(2). 122–126. 35 indexed citations

MacDonald, Anita, Gillian Harris, G Rylance, D. Asplin, & I W Booth. (1997). Abnormal feeding behaviours in phenylketonuria. Journal of Human Nutrition and Dietetics. 10(3). 163–170. 51 indexed citations

Rylance, G. (1996). Author's reply. BMJ. 313(7048). 49.2–49.2. 1 indexed citations

10.

Rylance, G, Caitlin J. Bowen, & Jamie Rylance. (1995). Measles and rubella immunisation: information and consent in children. BMJ. 311(7010). 923–924. 10 indexed citations

11.

MacDonald, Anita, et al.. (1994). Feeding problems in young PKU children. Acta Paediatrica. 83(s407). 73–74. 26 indexed citations

12.

Brenton, D. P., Jean Chapple, B. J. Clark, et al.. (1993). Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria.. Archives of Disease in Childhood. 68(3). 426–427. 217 indexed citations

13.

Thompson, Alan J., et al.. (1990). Neurological deterioration in young adults with phenylketonuria. The Lancet. 336(8715). 602–605. 158 indexed citations

14.

Rylance, G. (1990). Treatment of epilepsy and febrile convulsions in children. The Lancet. 336(8713). 488–491. 18 indexed citations

15.

Raafat, F., et al.. (1990). Juvenile Granulosa Cell Tumor. Pediatric Pathology. 10(4). 617–623. 23 indexed citations

16.

Rylance, G, et al.. (1988). Use of drugs by children.. BMJ. 297(6646). 445–447. 37 indexed citations

17.

Rylance, G. (1988). New Drugs: Prescribing for infants and children. BMJ. 296(6627). 984–986. 9 indexed citations

18.

Rylance, G. (1981). Clinical pharmacology. Drugs in children.. BMJ. 282(6257). 50–51. 10 indexed citations

19.

Rylance, G. (1981). Pediatric Pharmacology. Therapeutic Principles in Practice. Archives of Disease in Childhood. 56(11). 895–896. 27 indexed citations

20.

Rylance, G & T. A. Moreland. (1979). DRUG USE IN THE NEWBORN. Journal of Clinical Pharmacy and Therapeutics. 4(2). 95–100. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact